BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan W, Li W, Zhao J, Huang Z, Chen S, Wang C, Xue Y, Huang F, Fang Q, Wang J, Brand D, Zheng SG. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Mol Oncol. 2019;13:2246-2258. [PMID: 31368655 DOI: 10.1002/1878-0261.12553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Chen F, Zeng T, Tang Q, Chen B, Chen L, Dong Y, Li X. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma. Genes Dis 2021;8:157-67. [PMID: 33997162 DOI: 10.1016/j.gendis.2019.12.013] [Reference Citation Analysis]
2 Fang QL, Zhou JY, Xiong Y, Xie CR, Wang FQ, Li YT, Yin ZY, Luo GH. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis. Biosci Rep 2020;40:BSR20200297. [PMID: 32100822 DOI: 10.1042/BSR20200297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liang JH, Xu QD, Gu SG. LncRNA RSU1P2-microRNA let-7a-Testis-Expressed Protein 10 axis modulates tumorigenesis and cancer stem cell-like properties in liver cancer. Bioengineered 2022;13:4285-300. [PMID: 35156514 DOI: 10.1080/21655979.2022.2031394] [Reference Citation Analysis]
4 Mou Y, Sun Q. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1). Bioengineered 2022;13:746-58. [PMID: 34859735 DOI: 10.1080/21655979.2021.2012628] [Reference Citation Analysis]
5 Yang H, Yang H, Zhang W, Wang J, Sun L, Gao J, Zhao H, Wang Z, Aziz AUR. Identification of m6A-Related lncRNA to Predict the Prognosis of Patients with Hepatocellular Carcinoma. BioMed Research International 2022;2022:1-19. [DOI: 10.1155/2022/4169150] [Reference Citation Analysis]
6 Wang F, Cui D, Zhang Q, Shao Y, Zheng B, Chen L, Luo Y, Yuan L, Wang D. LncRNA00492 is required for marginal zone B-cell development. Immunology 2021. [PMID: 34435359 DOI: 10.1111/imm.13408] [Reference Citation Analysis]
7 Liu Y, Liu J, Cui J, Zhong R, Sun G. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis. Bioengineered 2022;13:1115-25. [PMID: 34978464 DOI: 10.1080/21655979.2021.2017678] [Reference Citation Analysis]
8 Jin C, Li R, Deng T, Li J, Yang Y, Li H, Chen K, Xiong H, Chen G, Wang Y. Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:784553. [PMID: 34988119 DOI: 10.3389/fmolb.2021.784553] [Reference Citation Analysis]
9 Feng Z, Ye Z, Xie J, Chen W, Li W, Xing C. Study on the mechanism of LOXL1-AS1/miR-3614-5p/YY1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma. Biol Direct 2021;16:24. [PMID: 34863279 DOI: 10.1186/s13062-021-00312-8] [Reference Citation Analysis]
10 Zhao JY, Li XY, Liu TD, Liang B, Huang Y, Li W. Silencing of ATG4D suppressed proliferation and enhanced cisplatin-induced apoptosis in hepatocellular carcinoma through Akt/Caspase-3 pathway. Mol Cell Biochem 2021. [PMID: 34313895 DOI: 10.1007/s11010-021-04224-z] [Reference Citation Analysis]
11 Zhang S, Zhou Y, Wang Y, Wang Z, Xiao Q, Zhang Y, Lou Y, Qiu Y, Zhu F. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years. Brief Bioinform 2021;22:1860-83. [PMID: 32249290 DOI: 10.1093/bib/bbaa023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Xu R, Zhang Y, Li A, Ma Y, Cai W, Song L, Xie Y, Zhou S, Cao W, Tang X. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. Mol Med Rep 2021;24:508. [PMID: 33982772 DOI: 10.3892/mmr.2021.12147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu Y, Wu Y, Liu S, Dai Y. Long Non-Coding RNA TRIM52-AS1 Promotes Growth and Metastasis via miR-218-5p/ROBO1 in Hepatocellular Carcinoma. Cancer Manag Res 2021;13:547-58. [PMID: 33519234 DOI: 10.2147/CMAR.S286205] [Reference Citation Analysis]
14 Han J, Shen X. Long noncoding RNAs in osteosarcoma via various signaling pathways. J Clin Lab Anal 2020;34:e23317. [PMID: 32249459 DOI: 10.1002/jcla.23317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
15 Peng Z, Ouyang X, Wang Y, Fan Q. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis. BMC Mol Cell Biol 2022;23:21. [PMID: 35468721 DOI: 10.1186/s12860-022-00420-x] [Reference Citation Analysis]
16 Huang C, Liu J, He L, Wang F, Xiong B, Li Y, Yang X. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development. Bioengineered 2021;12:11738-55. [PMID: 34895039 DOI: 10.1080/21655979.2021.2009412] [Reference Citation Analysis]
17 Zhang, Zhang X, Zhao W, Xiao X, Liu S, Peng Q, Jiang N, Zhou B. NLRP6-Dependent Pyroptosis-Related lncRNAs Predict the Prognosis of Hepatocellular Carcinoma. Front Med (Lausanne) 2022;9:760722. [PMID: 35308537 DOI: 10.3389/fmed.2022.760722] [Reference Citation Analysis]
18 Liang H, Wu JG, Wang F, Chen BX, Zou ST, Wang C, Luo SW. Expression of caspase-3 and hypoxia inducible factor 1α in hepatocellular carcinoma complicated by hemorrhage and necrosis. World J Clin Cases 2021; 9(23): 6725-6733 [PMID: 34447819 DOI: 10.12998/wjcc.v9.i23.6725] [Reference Citation Analysis]
19 Li M, Wei L, Liu PY, Zhang XM, Liu F, Yang F, Hu XS, Mo ZC. Lnc-ATG9B-4 aggravates progress of hepatocellular carcinoma through cell proliferation and migration by upregulating CDK5. Exp Biol Med (Maywood) 2021;246:177-86. [PMID: 33023330 DOI: 10.1177/1535370220963197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Stasiak M, Kolenda T, Kozłowska-masłoń J, Sobocińska J, Poter P, Guglas K, Paszkowska A, Bliźniak R, Teresiak A, Kazimierczak U, Lamperska K. The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules? Life 2021;11:1354. [DOI: 10.3390/life11121354] [Reference Citation Analysis]
21 Chen S. LINC00852 Regulates Cell Proliferation, Invasion, Migration and Apoptosis in Hepatocellular Carcinoma Via the miR-625/E2F1 Axis. Cel Mol Bioeng . [DOI: 10.1007/s12195-021-00714-8] [Reference Citation Analysis]
22 Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol 2021;11:649107. [PMID: 33968749 DOI: 10.3389/fonc.2021.649107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Wu J, Tang X, Shi Y, Ma C, Zhang H, Zhang J, Lu Y, Wei J, Li L, Han L. β-Elemene suppresses hepatocellular carcinoma cell growth via mediating LncRNA HOTAIR / SP1 / PDK1 axis impact of β-elemene on hepatocellular carcinoma cells growth. J Ethnopharmacol 2021;:114456. [PMID: 34333105 DOI: 10.1016/j.jep.2021.114456] [Reference Citation Analysis]
24 Liang W, Ke J. Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR‐650/TIMP3 axis. Int J Experimental Path. [DOI: 10.1111/iep.12429] [Reference Citation Analysis]
25 Xing Y, Lin Y, Zhang Y, Hu J, Liu J, Tian Y, Zhao J, Chen W, Han B. Novel cytoplasmic lncRNA IKBKBAS promotes lung adenocarcinoma metastasis by upregulating IKKβ and consequential activation of NF-κB signaling pathway. Cell Death Dis 2021;12:1004. [PMID: 34702815 DOI: 10.1038/s41419-021-04304-4] [Reference Citation Analysis]
26 Jiang Y, Luo K, Xu J, Shen X, Gao Y, Fu W, Zhang X, Wang H, Liu B. Integrated Analysis Revealing the Senescence-Mediated Immune Heterogeneity of HCC and Construction of a Prognostic Model Based on Senescence-Related Non-Coding RNA Network. Front Oncol 2022;12:912537. [DOI: 10.3389/fonc.2022.912537] [Reference Citation Analysis]
27 Huang H, He X, Huang X, Wang G, Xia Q, Du Z, Zhang Y. Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00833-3] [Reference Citation Analysis]
28 Ashrafizadeh M, Zarrabi A, Orouei S, Zabolian A, Saleki H, Azami N, Bejandi AK, Mirzaei S, Janaghard MN, Hushmandi K, Nabavi N, Baradaran B, Kumar AP, Makvandi P, Samarghandian S, Khan H, Hamblin MR. Interplay between SOX9 transcription factor and microRNAs in cancer. Int J Biol Macromol 2021;183:681-94. [PMID: 33957202 DOI: 10.1016/j.ijbiomac.2021.04.185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Liu J, Yu H, Wei F, Cui H, Yan T, Li T, Liu Y, Chu J. lncRNA LINC000466 predicts the prognosis and promotes the progression of triple-negative breast cancer via modulating miR-539-5p. Clinical Breast Cancer 2022. [DOI: 10.1016/j.clbc.2022.01.011] [Reference Citation Analysis]
30 Wu Y, Zhang Y, Qin X, Geng H, Zuo D, Zhao Q. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacol Res 2020;160:105195. [PMID: 32916254 DOI: 10.1016/j.phrs.2020.105195] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
31 Zhang Y, Zhang H, Zhang X, Liu B. CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4. Dis Markers 2022;2022:7155525. [PMID: 35655916 DOI: 10.1155/2022/7155525] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Huang A, Li T, Xie X, Xia J. Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma. Front Mol Biosci 2021;8:759173. [PMID: 34901153 DOI: 10.3389/fmolb.2021.759173] [Reference Citation Analysis]
33 Lou W, Ding B, Fu P. Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Front Cell Dev Biol 2020;8:85. [PMID: 32185172 DOI: 10.3389/fcell.2020.00085] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 19.0] [Reference Citation Analysis]
34 Liu Z, Wang Q, Zhai G, Ke S, Yu X, Guo J. SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02546-6] [Reference Citation Analysis]
35 Chen G, Zhang Z, Li Y, Wang L, Liu Y. LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG. J Oncol 2021;2021:3624306. [PMID: 34876904 DOI: 10.1155/2021/3624306] [Reference Citation Analysis]
36 Tan C, Zeng X, Mo M, Ma X, Liang Q, Liang W, Huang W, Wang K, Yang L, Qiu X. RNA sequencing identifies two novel liver-specific long noncoding RNAs with potential diagnostic value in hepatocellular carcinoma. Biomark Med 2021;15:1097-109. [PMID: 34128691 DOI: 10.2217/bmm-2020-0825] [Reference Citation Analysis]
37 Shen S, Wang Y, Zhang Y, Dong Z, Xing J. Long Non-coding RNA Small Nucleolar RNA Host Gene 14, a Promising Biomarker and Therapeutic Target in Malignancy. Front Cell Dev Biol 2021;9:746714. [PMID: 34631721 DOI: 10.3389/fcell.2021.746714] [Reference Citation Analysis]
38 Deng X, Cheng J, Zhan N, Chen J, Zhan Y, Ni Y, Liao C. MicroRNA-135a expression is upregulated in hepatocellular carcinoma and targets long non-coding RNA TONSL-AS1 to suppress cell proliferation. Oncol Lett 2021;22:808. [PMID: 34630715 DOI: 10.3892/ol.2021.13069] [Reference Citation Analysis]
39 Zhong B, Dong J, Zhang R, He M, Zeng W, Pan J, He J, Tao A, Yang R, Fu B, French SW, Liu H. Altered regulation of LncRNA analysis of human alcoholic hepatitis with Mallory-Denk Bodies (MDBs) is revealed by RNA sequencing. Exp Mol Pathol 2020;117:104559. [PMID: 33121977 DOI: 10.1016/j.yexmp.2020.104559] [Reference Citation Analysis]
40 Hu Z, Chen Y, Zhu S, Feng X, Zhang B, Huang J, Song J. Sonic Hedgehog Promotes Proliferation and Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Rho/ROCK Signaling. Journal of Immunology Research 2022;2022:1-9. [DOI: 10.1155/2022/3423692] [Reference Citation Analysis]
41 Ren H, Wei ZC, Sun YX, Qiu CY, Zhang WJ, Zhang W, Liu T, Che X. ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM. Front Oncol 2021;11:714264. [PMID: 34513693 DOI: 10.3389/fonc.2021.714264] [Reference Citation Analysis]
42 Li F, Qasim S, Li D, Dou QP. Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Semin Cancer Biol 2021:S1044-579X(20)30256-X. [PMID: 33453404 DOI: 10.1016/j.semcancer.2020.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Reghupaty SC, Sarkar D. Current Status of Gene Therapy in Hepatocellular Carcinoma. Cancers (Basel) 2019;11:E1265. [PMID: 31466358 DOI: 10.3390/cancers11091265] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
44 Wang J, Wang W, Tang Q, Lu L, Luo Z, Li W, Lu Y, Pu J. Long Non-coding RNA lnc-GNAT1-1 Suppresses Liver Cancer Progression via Modulation of Epithelial-Mesenchymal Transition. Front Genet 2020;11:1029. [PMID: 33193591 DOI: 10.3389/fgene.2020.01029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Sisu C. Pseudogenes as Biomarkers and Therapeutic Targets in Human Cancers. Methods Mol Biol 2021;2324:319-37. [PMID: 34165724 DOI: 10.1007/978-1-0716-1503-4_20] [Reference Citation Analysis]
46 Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database. Transl Cancer Res 2021;10:5337-51. [PMID: 35116381 DOI: 10.21037/tcr-21-2440] [Reference Citation Analysis]
47 Cao J, Wu L, Lei X, Shi K, Shi L, Shi Y. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma. Bioengineered 2021;12:673-81. [PMID: 33622186 DOI: 10.1080/21655979.2021.1878763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Huang XY, Huang ZL, Huang J, Xu B, Huang XY, Xu YH, Zhou J, Tang ZY. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 2020;39:20. [PMID: 31973767 DOI: 10.1186/s13046-020-1529-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 70] [Article Influence: 29.0] [Reference Citation Analysis]
49 Xue C, Li G, Lu J, Luo J, Jia J. Novel insights for lncRNA MAGI2-AS3 in solid tumors. Biomed Pharmacother 2021;137:111429. [PMID: 33761624 DOI: 10.1016/j.biopha.2021.111429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Qin Z, Liu X, Li Z, Wang G, Feng Z, Liu Y, Yang H, Tan C, Zhang Z, Li K. LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge. Cell Death Discov 2021;7:387. [PMID: 34907204 DOI: 10.1038/s41420-021-00787-4] [Reference Citation Analysis]
51 Shen C, Li J, Zhang Q, Tao Y, Li R, Ma Z, Wang Z. LncRNA GASAL1 promotes hepatocellular carcinoma progression by up-regulating USP10-stabilized PCNA. Exp Cell Res 2021;:112973. [PMID: 34914965 DOI: 10.1016/j.yexcr.2021.112973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]